There are also studies on the diagnostic value of circulating CgA in the diagnosis of prostate cancer, but there are differences between the results, with some studies showing that circulating CgA levels are higher in prostate cancer patients than in non-prostate cancer patients (40–42). This evidence concerns the gene CGA and prostate carcinoma.